Edition:
United States

Arcadia Biosciences Inc (RKDA.OQ)

RKDA.OQ on NASDAQ Stock Exchange Capital Market

7.43USD
20 Jul 2018
Change (% chg)

$-0.18 (-2.37%)
Prev Close
$7.61
Open
$7.56
Day's High
$7.72
Day's Low
$7.21
Volume
34,692
Avg. Vol
153,061
52-wk High
$66.42
52-wk Low
$3.60

Chart for

About

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of developmen... (more)

Overall

Beta: --
Market Cap(Mil.): $36.33
Shares Outstanding(Mil.): 4.77
Dividend: --
Yield (%): --

Financials

  RKDA.OQ Industry Sector
P/E (TTM): -- 23.37 22.42
EPS (TTM): -10.24 -- --
ROI: -65.94 9.74 7.54
ROE: -232.23 13.52 9.95

BRIEF-Arcadia Biosciences Q1 Revenue Fell 79 Percent To $214,000

* ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

May 09 2018

BRIEF-Arcadia Biosciences Files Prospectus Related To Sale Of Up To 2.9 Mln Shares Of Common Stock By Selling Shareholders

* ARCADIA BIOSCIENCES FILES PROSPECTUS RELATED TO SALE OF UP TO 2.9 MILLION SHARES OF COMMON STOCK BY SELLING SHAREHOLDERS - SEC FILING Source text: (https://bit.ly/2uyTUPD) Further company coverage:

Mar 30 2018

BRIEF-Arcadia Biosciences Q4 Loss Per Share $1.39

* ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

Mar 20 2018

BRIEF-Arcadia Biosciences Welcomes New Chief Commercial Officer

* ARCADIA BIOSCIENCES - SARAH REITER JOINED CO'S EXECUTIVE TEAM AS CHIEF COMMERCIAL OFFICER Source text for Eikon: Further company coverage:

Mar 20 2018

BRIEF-Arcadia Biosciences Announces $10 Mln Private Placement

* ARCADIA BIOSCIENCES ANNOUNCES $10 MILLION PRIVATE PLACEMENT

Mar 19 2018

Earnings vs. Estimates